Related Experiment Videos
NRG-3 in human breast cancers: activation of multiple erbB family proteins
M M Hijazi1, P E Young, M K Dougherty
1Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Abstract:
Ligands of the EGF/Heregulin family control the growth of epithelial cells by binding to receptors of the erbB family. By searching a large database of cDNA sequences at Human Genome Sciences Inc. we have identified a new encoded protein sequence containing all the conserved elements of the EGF/Heregulin family. The same sequence has recently been independently identified as NRG-3. The EGF-like domain of NRG-3 was generated as a recombinant protein in E. coli and used to test the specificity of receptor binding. In human breast cancer cells and in 32D cells transfected by erbB family members, NRG-3 activated multiple erbB family members. These include EGF receptor (erbB1) and erbB4 when expressed individually and erbB2 and erbB3 when expressed together. Recombinant NRG-3 altered the growth of human breast cancer cells growing in vitro. NRG-3 was expressed in cell lines derived from breast cancer. These results indicate that NRG-3 is a potential regulator of normal and malignant breast epithelial cells in vivo.
Insights
We discovered Neuregulin-3 (NRG-3), a new member of the EGF/Heregulin family. NRG-3 activates multiple erbB receptors and influences breast cancer cell growth, suggesting its role in breast epithelial cell regulation.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- EGF/Heregulin family ligands regulate epithelial cell growth via erbB receptors.
- Identification of novel ligands is crucial for understanding cell signaling pathways.
Purpose of the Study:
- To identify and characterize a new member of the EGF/Heregulin family.
- To investigate the receptor binding specificity and cellular effects of the novel ligand, NRG-3.
- To assess the role of NRG-3 in breast cancer cell regulation.
Main Methods:
- cDNA sequence database search for novel EGF/Heregulin family members.
- Recombinant protein expression (EGF-like domain of NRG-3) in E. coli.
- Receptor binding assays and cell proliferation studies in human breast cancer cells and transfected 32D cells.
- Analysis of NRG-3 expression in breast cancer cell lines.
Main Results:
- A novel protein sequence, NRG-3, with conserved EGF/Heregulin family elements was identified.
- Recombinant NRG-3 activated multiple erbB family members, including EGFR (erbB1), erbB4, erbB2, and erbB3.
- NRG-3 altered the in vitro growth of human breast cancer cells.
- NRG-3 was found to be expressed in breast cancer cell lines.
Conclusions:
- NRG-3 is a novel ligand that activates multiple erbB receptors.
- NRG-3 influences the growth of breast cancer cells.
- NRG-3 is a potential regulator of normal and malignant breast epithelial cells in vivo.